Amazon Expands AI Shopping Technology to Retail Partners Signs Kate Spade as First Customer US Retail Sales Show Resilience Amid Persistent Cost Pressures ING Analysis PNC Infratech Could See Significant Upside as Brokerages Highlight Growth Drivers After Q4 Results Plus500 Revenue Rises 11 in Latest Quarter Company Expects to Meet FullYear Targets Vestas Wind Systems Shares Decline After Margins Guidance Disappoints BP Chairman Abruptly Removed Amid Reports of Bullying and Overbearing Conduct MUFG Q1 2026 Earnings Strong EPS Beat Amid Cautious Market Sentiment MGPI Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiencies Mobile Infrastructure Corporation BEEP Q1 2026 Earnings NarrowerThanExpected Loss Despite Stock Decline AVXL Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances APH Q1 2026 Earnings EPS Surges Past Estimates Signaling Strong Operational Momentum DGICA Q1 2026 Earnings EPS Misses Estimates Stock Declines Watts Water Technologies WTS Edges Higher Amid Steady Demand and Industrial Trends Beazer Homes BZH Sees Uptick as Market Tests Key Resistance Near 2558 CIT Inc CINT Edges Higher Navigating Key Support and Resistance Levels Hall Chadwick Acquisition Corp Rights HCACR Holds Steady at 029 Sideways Action in a Tight Range Morgan Stanley Emerging Markets Domestic Debt Fund EDD Rises 11 as Emerging Market Debt Shows Resilience GSRF GSR IV Acquisition Corp Holds Steady at 1013 as Consolidation Defines the Session National Fuel Gas NFG Edges Lower Maintains Position Above Key Support TPG Mortgage Investment Trust MITT Gains 17 as Mortgage REIT Sector Sees Renewed Interest Offerpad Solutions OPAD Edges Higher as Stock Tests Key Resistance Zone SenesTech Inc SNES Edges Higher Approaching Key Resistance at 190 PowerBank Corporation SUUN Slips Marginally as Traders Eye Key Support at 098 Dhoot Transmission Files Updated DRHP for 1400 Crore IPO with Sebi BioCardia Inc BCDA Q1 2026 Earnings WiderthanExpected Loss as PreRevenue ClinicalStage Firm Advances Trials Recursion Pharmaceuticals RXRX Slips 13 as Biotech Stock Tests Key Support Near 282